We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+7.23%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.7B
AUM Growth
-$2.27B
Cap. Flow
-$3.05B
Cap. Flow %
-17.25%
Top 10 Hldgs %
15.77%
Holding
1,947
New
557
Increased
335
Reduced
444
Closed
606

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$113M
2
BERY
Berry Global Group, Inc.
BERY
+$106M
3
MRK icon
Merck
MRK
+$95.9M
4
BIDU icon
Baidu
BIDU
+$85.8M
5
IQV icon
IQVIA
IQV
+$83.1M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$229M
2
LVS icon
Las Vegas Sands
LVS
+$150M
3
BABA icon
Alibaba
BABA
+$131M
4
C icon
Citigroup
C
+$130M
5
MU icon
Micron Technology
MU
+$105M

Sector Composition

Rank Sector Weight
1 Healthcare 24.85%
2 Technology 15.39%
3 Consumer Discretionary 13.45%
4 Industrials 10.48%
5 Financials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HOME
101
DELISTED
At Home Group Inc.
HOME
$43.6M 0.25%
1,113,247
+1,105,360
+14,015% +$39.7M
EQIX icon
102
Equinix
EQIX
$104B
$43M 0.24%
99,954
+40,974
+69% +$16.6M
BCO icon
103
Brink's
BCO
$4.6B
$42.9M 0.24%
537,542
-110,207
-17% -$8.34M
ASND icon
104
Ascendis Pharma A/S
ASND
$16.3B
$42.5M 0.24%
639,547
+66,676
+12% +$4.38M
TSM icon
105
TSMC
TSM
$2.18T
$42.3M 0.24%
1,157,600
+923,672
+395% +$36.5M
BKNG icon
106
Booking.com
BKNG
$156B
$42.2M 0.24%
520,950
-522,325
-50% -$44M
LULU icon
107
lululemon athletica
LULU
$14.2B
$42.1M 0.24%
337,263
-141,454
-30% -$15.1M
BAC icon
108
Bank of America
BAC
$440B
$41.8M 0.24%
1,482,884
+1,289,120
+665% +$38.5M
COLM icon
109
Columbia Sportswear
COLM
$2.96B
$40.1M 0.23%
437,956
+206,300
+89% +$17.6M
MRTX
110
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$39.7M 0.22%
804,776
+495,017
+160% +$18.7M
WCG
111
DELISTED
Wellcare Health Plans, Inc.
WCG
$39.1M 0.22%
158,856
+84,394
+113% +$18.4M
BRKR icon
112
Bruker
BRKR
$7.82B
$38.7M 0.22%
1,334,051
+132,585
+11% +$4.03M
CMA
113
DELISTED
Comerica
CMA
$38.7M 0.22%
425,783
+334,539
+367% +$32.1M
HD icon
114
Home Depot
HD
$348B
$38.7M 0.22%
198,398
+191,382
+2,728% +$35.7M
ADT icon
115
ADT
ADT
$5.63B
$38.4M 0.22%
4,439,908
-103,997
-2% -$863K
AJG icon
116
Arthur J. Gallagher & Co
AJG
$64B
$38.3M 0.22%
587,044
-118,786
-17% -$8.04M
BRO icon
117
Brown & Brown
BRO
$23.8B
$37.7M 0.21%
1,360,724
+310,888
+30% +$8.46M
CVS icon
118
CVS Health
CVS
$124B
$37.6M 0.21%
584,429
+445,645
+321% +$29.4M
SRPT icon
119
Sarepta Therapeutics
SRPT
$1.75B
$37M 0.21%
279,841
-86,392
-24% -$8.15M
TIF
120
DELISTED
Tiffany & Co.
TIF
$36.5M 0.21%
277,643
+154,853
+126% +$17.7M
VG
121
DELISTED
Vonage Holdings Corporation
VG
$36.4M 0.21%
2,823,218
+1,516,945
+116% +$17.4M
C icon
122
Citigroup
C
$226B
$35.9M 0.2%
536,947
-1,893,037
-78% -$130M
MTB icon
123
M&T Bank
MTB
$36.2B
$35.8M 0.2%
+210,208
New +$37.7M
PANW icon
124
Palo Alto Networks
PANW
$290B
$35.5M 0.2%
1,037,748
-506,178
-33% -$16.9M
MTDR icon
125
Matador Resources
MTDR
$6.05B
$35.5M 0.2%
+1,182,121
New +$35.7M
3 4
5
6 7

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q2 2018 Portfolio in Review

As of Q2 2018, Marshall Wace North America held 1,947 positions worth $17.7B, down 11% from $20B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America withdrew a net $3.05B in Q2 2018, closing 606 positions and reducing 444 holdings. Its most notable exit was Time Warner Inc, an estimated $63.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Marshall Wace North America opened a new position in IQVIA worth $83.1M.

  • Marshall Wace North America's largest Q2 2018 buy was IQVIA: 832,159 shares worth $83.1M.
  • Marshall Wace North America added most to Vertex Pharmaceuticals in Q2 2018, an estimated $113M increase.
  • Marshall Wace North America's biggest Q2 2018 reduction was Johnson & Johnson, cutting an estimated $229M.
  • Marshall Wace North America fully exited Time Warner Inc in Q2 2018, selling an estimated $63.3M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $17.7B portfolio in Q2 2018.
  • Marshall Wace North America opened 557 new positions and closed 606 in Q2 2018.
  • Marshall Wace North America's portfolio value fell 11% quarter-over-quarter to $17.7B.

Based on Marshall Wace North America's 13F filing for Q2 2018, filed 14 Aug 2018.